This may be explained by the use of CRT in the more intensive treatment regimens, which increased the risk of infection, whereas obesity, which was more prevalent in patients homozygous for rs9939609A variant of the FTO gene, causes impaired liver function due to activation of the insulin pathway and may be associated with higher susceptibility to infections. The gene discussed is FTO; the disease is Obesity.